Evidence map›Paper›PMID 36421442›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Bo-Jeong Pyun, Kyuhyung Jo, Joo Young Lee, Ami Lee, Myung-A Jung, Youn-Hwan Hwang, Dong Ho Jung, Kon-Young Ji, Susanna Choi, Yun Hee Kim and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Heliyon · 2025
    Article
  6. An Investigation of the Anticancer Mechanism ofPlants (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Review
  9. Unlocking the therapeutic mechanism ofFrontiers in pharmacology · 2024
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Bo-Jeong PyunKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.ORCID 0000-0003-3261-9310
Kyuhyung JoKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
Joo Young LeeKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.ORCID 0000-0001-8761-5187
Ami LeeKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
Myung-A JungKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.ORCID 0000-0003-3132-7308
Youn-Hwan HwangKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.ORCID 0000-0002-4959-2436
Dong Ho JungKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.ORCID 0000-0002-6250-5720
Kon-Young JiKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.ORCID 0000-0003-3992-8925
Susanna ChoiKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.ORCID 0000-0003-2714-1754
Yun Hee KimKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
Taesoo KimKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
Korea Institute of Oriental Medicine · KR

Funding

Korea Institute of Oriental Medicine KSN2013330
6 · The paper itself

Abstract

Allergic rhinitis (AR) is a common upper-airway inflammatory disease of the nasal mucosa caused by immunoglobulin (IgE)-mediated inflammation. AR causes various painful clinical symptoms of the nasal mucosa that worsen the quality of daily life, necessitating the urgent development of therapeutic agents. Herein, we investigated the effects of

Indexed as

allergic rhinitisantioxidantCaesalpinia sappan Linn.inflammationKeap1/Nrf2/HO-1 signaling pathwayROSTh2 cytokine

Identifiers

PMID36421442
PMCPMC9686907
OpenAlexW4309118870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.